F. Hoffmann-La Roche Ltd. (hereafter 'Roche') [Head Office: Basel, Switzerland. CEO: Severin Schwan] announced its first quarter sales 2022 (January 1 - March 31, 2022).
Roche owns 59.89% of Chugai's outstanding shares (61.16% of voting rights) as of the end of December 2021.
Its investor update and presentation materials can be found on its website (https://www.roche.com/).
Chugai's performance for the period of January 1 to March 31, 2022 is included in the announced Roche Group's results.
Chugai Pharmaceutical Co., Ltd.
Media Relations Group
Corporate Communications Dept.,
(C) 2022 Electronic News Publishing, source ENP Newswire